Beste apotheek van Nederland

Fein R L. Classification of sexual dysfunction for management
of intracavernous medication-induced erections.[see comment].
Br J Urol 1990;143(2):298-301.
Feldman R, Meuleman E J, Steers W. Sildenafil citrate
(VIAGRA) in the treatment of erectile dysfunction: analysis of
two flexible dose-escalation studies. Sildenafil Study Group. Int
J Clin Pract 1999;102(Suppl Jun.):100-102.
Fink H A, Mac Donald R, Rutks I R et al. Sildenafil for male
erectile dysfunction: a systematic review and meta-analysis.
Arch Intern Med 2002;162(12):1349-1360.
Fink H A, MacDonald R, Rutks I R et al. Trazodone for erectile
dysfunction: a systematic review and meta-analysis. BJU Int
2003;92(4):441-446.
Fishbain David A. Impact of sildenafil on male erectile disorder
due to psychological factors. Can J Psychiatry 2000;45(1):85­
86.
Flack J M. The effect of doxazosin on sexual function in patients
with benign prostatic hyperplasia, hypertension, or both.[see
comment]. [Review] [47 refs]. Int J Clin Pract 2002;56(7):527­
530.
Fonseca V, Seftel A, Denne J et al. Impact of diabetes mellitus
on the severity of erectile dysfunction and response to treatment:
analysis of data from tadalafil clinical trials. Diabetologia
2004;47(11):1914-1923.
Foresta C, Caretta N, Lana A et al. Relationship Between
Vascular Damage Degrees and Endothelial Progenitor Cells in
Patients with Erectile Dysfunction: Effect of Vardenafil
Administration and PDE5 Expression in the Bone Marrow. Eur
Urol 2007;51(5):1411-1419.
Foresta C, Ferlin A, De Toni L et al. Circulating endothelial
progenitor cells and endothelial function after chronic Tadalafil
treatment in subjects with erectile dysfunction. Int J Impot Res
2006;18(5):484-488.
Foulks C J, Cushner H M. Sexual dysfunction in the male
dialysis patient: pathogenesis, evaluation, and therapy. [Review]
[105 refs]. Am J Kidney Dis 1986;8(4):211-222.
Fox K M, Thadani U, Ma P T et al. Sildenafil citrate does not
reduce exercise tolerance in men with erectile dysfunction and
chronic stable angina. Eur Heart J 2003;24(24):2206-2212.
Freitas D, Athanazio R, Almeida D et al. Sildenafil improves
quality of life in men with heart failure and erectile dysfunction.
Int J Impot Res 2006;18(2):210-212.
Fugl-Meyer A R, Lodnert G, Branholm I B et al. On life
satisfaction in male erectile dysfunction. Int J Impot Res
1997;9(3):141-148.
Fugl-Meyer K S, Stothard D, Belger M et al. The effect of
tadalafil on psychosocial outcomes in Swedish men with erectile
distress: a multicentre, non-randomised, open-label clinical
study. Int J Clin Pract 2006;60(11):1386-1393.
Fujisawa M, Sawada K. Clinical efficacy and safety of
sildenafil in elderly patients with erectile dysfunction.
Arch Androl 2004;50(4):255-260.
Fulgham P F, Cochran J S, Denman J L et al.
Disappointing initial results with transurethral
alprostadil for erectile dysfunction in a urology
practice setting.. Br J Urol 1998;160(6 Pt 1):2041­
2046.
Gana T E, Quizanos L F, Castell R et al. A doseresponse
study of alprostadil in patients with erectile
dysfunction. Curr Ther Res Clin Exp 1996;57(9):700­
710.
Garcia-Bravo A M, Suarez-Hernandez D, Ruiz-
Fernandez M A et al. Determination of changes in
blood pressure during administration of sildenafil
(Viagra) in patients with spinal cord injury and erectile
dysfunction. Proc Annu Clin Spinal Cord Inj Conf
2006;44(5):301-308.
Ghanem H, Sherif T, bdEl-Gawad T et al. Short term
use of intracavernous vasoactive drugs in the
treatment of persistent psychogenic erectile
dysfunction. Int J Impot Res 1998;10(4):211-214.
Gheorghiu S, Godschalk M, Gentili A et al. Quality of
life in patients using self-administered intracavernous
injections of prostaglandin E1 for erectile dysfunction.
Br J Urol 1996;156(1):80-81.
Giammusso B, Morgia G, Spampinato A et al.
Improved pallesthetic sensitivity of pudendal nerve in
impotent diabetic patients treated with acetyl-Lcarnitine.
Acta Urologica Italica 1996;10(3):185-187.
Gil A, Martinez E, Oyaguez I et al. Erectile
dysfunction in a primary care setting: results of an
observational, no-control-group, prospective study
with sildenafil under routine conditions of use. Int J
Impot Res 2001;13(6):338-347.
Gilbert H W, Gingell J C. The results of an
intracorporeal papaverine clinic. Sex Marital Ther
1991;6(1):49-56.
Gilbert H W, Gillatt D A, Desai K M et al.
Intracorporeal papaverine injection in androgen
deprived men. J R Soc Med 1990;83(3):161
Gilbert R N, Graham C W, Regan J B. Double-blindcross-over
trial of testosterone enanthate in impotent
men with low or low-normal serum testosterone
levels. Br J Urol 1992;147264
Gillies H C, Roblin D, Jackson G. Coronary and
systemic hemodynamic effects of sildenafil citrate:
From basic science to clinical studies in patients with
cardiovascular disease. Int J Cardiol 2002;86(2­
3):131-141.
D-167